Ptc Therapeutics (PTCT) Prepaid Assets (2012 - 2026)
Ptc Therapeutics' (PTCT) quarterly Prepaid Assets came in at $66.1 million in Q1 2026, up 15.77% year-on-year from $57.1 million in Q1 2025, and down 1.86% quarter-over-quarter from $67.3 million in Q4 2025.
Ptc Therapeutics (PTCT) Prepaid Assets (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Prepaid Assets history runs 15 years deep, the most recent figure standing at $66.1 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 15.77% year-over-year to $66.1 million in Q1 2026; TTM through Mar 2026 was $66.1 million, a 15.77% increase from a year earlier, with the FY2025 full-year figure at $67.3 million, up 52.67% from the prior year.
- Prepaid Assets slipped to $66.1 million in Q1 2026 per PTCT's latest filing, from $67.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $150.5 million in Q4 2023 and bottomed at $29.6 million in Q1 2022.
- The 5-year median for Prepaid Assets is $56.2 million (2024), against an average of $63.8 million.
- Across the five-year window, Prepaid Assets soared 232.49% in 2023 and plunged 70.7% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $105.7 million in 2022, then jumped by 42.43% to $150.5 million in 2023, then plunged by 70.7% to $44.1 million in 2024, then soared by 52.67% to $67.3 million in 2025, then declined by 1.86% to $66.1 million in 2026.
- Per Business Quant, the three latest PTCT Prepaid Assets figures stand at $66.1 million (Q1 2026), $67.3 million (Q4 2025), and $64.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.05 Mn |
| Dec 31, 2025 | 67.31 Mn |
| Sep 30, 2025 | 64.22 Mn |
| Jun 30, 2025 | 53.53 Mn |
| Mar 31, 2025 | 57.06 Mn |
| Dec 31, 2024 | 44.09 Mn |
| Sep 30, 2024 | 32.55 Mn |
| Jun 30, 2024 | 45.64 Mn |
| Mar 31, 2024 | 56.21 Mn |
| Dec 31, 2023 | 150.49 Mn |
| Sep 30, 2023 | 44.08 Mn |
| Jun 30, 2023 | 42.23 Mn |
| Mar 31, 2023 | 98.57 Mn |
| Dec 31, 2022 | 105.66 Mn |
| Sep 30, 2022 | 89.56 Mn |
| Jun 30, 2022 | 38.18 Mn |
| Mar 31, 2022 | 29.65 Mn |
| Dec 31, 2021 | 54.68 Mn |
| Sep 30, 2021 | 30.94 Mn |
| Jun 30, 2021 | 23.91 Mn |